First FDA-approved beta-amyloid diagnostic hits the market.
Ken
K
Garber
D000544:Alzheimer Disease / Q000175:diagnosis*; D016229:Amyloid beta-Peptides / Q000032:analysis*; D003287:Contrast Media; D003952:Diagnostic Imaging; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D016229:Amyloid beta-Peptides; D003287:Contrast Media